| Статус: | Completed |
| Фаза: | Phase 4 |
| Начало: | 3 августа 2017 г. |
| Окончание: | 31 июля 2020 г. |
| Описание: | The purpose of this study is to evaluate immunogenicity, epidemiological efficacy and safety of medicinal product GamEvac-Combi - Combined Vector-Based Vaccine against Ebola Virus Disease, 0.5 ml+0.5 ml/dose |
| смотреть на ClinicalTrials.gov |